Ikezu Honored by Alzhemier’s Association for “Most Impactful Study in the Last Two Years”

Tsuneya Ikezu, MD, PhD, professor of pharmacology & experimental therapeutics and neurology at Boston University School of Medicine (BUSM), recently received the Alzheimer’s Association’s Inge Grundke-Iqbal Award for Alzheimer’s Research. The award was presented at the Alzheimer’s Association International Conference® 2016 in Toronto.

Ikezu received the award for research that found brain immune cells called microglia may play an adverse role in transporting toxic tau protein during the early stages of Alzheimer’s disease. In the study, Ikezu and colleagues found that removing microglia from the brains of mice suppressed the spread of tau from one brain region to another. They also found that small vesicles called exosomes are implicated in the spared of tau. Researchers suggest this may be a viable therapeutic pathway to slow the progression of Alzheimer’s.

For more on Tsuneya Ikezu's research, go to: 
https://www.bumc.bu.edu/busm/2016/07/27/ikezu-honored-by-alzhemiers-association-for-most-impactful-study-in-the-last-two-years/